Lysko PG - Search Results

1

Identification of a small-molecule, nonpeptide macrophage scavenger receptor antagonist.

Lysko PG, Weinstock J, Webb CL, Brawner ME, Elshourbagy NA. Lysko PG, et al. J Pharmacol Exp Ther. 1999 Jun;289(3):1277-85. J Pharmacol Exp Ther. 1999. PMID: 10336517

2

Binding of the nonpeptide antagonist, SB 209670, to endothelin receptors on cultured neurons.

Lysko PG, Webb CL, Feuerstein G. Lysko PG, et al. Peptides. 1995;16(7):1279-82. doi: 10.1016/0196-9781(95)00096-3. Peptides. 1995. PMID: 8545251

3

Molecular characterization of a human scavenger receptor, human MARCO.

Elshourbagy NA, Li X, Terrett J, Vanhorn S, Gross MS, Adamou JE, Anderson KM, Webb CL, Lysko PG. Elshourbagy NA, et al. Among authors: lysko pg. Eur J Biochem. 2000 Feb;267(3):919-26. doi: 10.1046/j.1432-1327.2000.01077.x. Eur J Biochem. 2000. PMID: 10651831 Free article.

4

Neuroprotective effects of carvedilol, a new antihypertensive, at the N-methyl-D-aspartate receptor.

Lysko PG, Lysko KA, Webb CL, Feuerstein G. Lysko PG, et al. Among authors: lysko ka. Neurosci Lett. 1992 Dec 14;148(1-2):34-8. doi: 10.1016/0304-3940(92)90798-c. Neurosci Lett. 1992. PMID: 1300500

5

Developmental expression of endothelin receptors in cerebellar neurons differentiating in culture.

Lysko PG, Elshourbagy NA, Pullen M, Nambi P. Lysko PG, et al. Brain Res Dev Brain Res. 1995 Aug 28;88(1):96-101. doi: 10.1016/0165-3806(95)00087-t. Brain Res Dev Brain Res. 1995. PMID: 7493411

6

Neuroprotective effects of carvedilol, a new antihypertensive, as a Na+ channel modulator and glutamate transport inhibitor.

Lysko PG, Webb CL, Feuerstein G. Lysko PG, et al. Neurosci Lett. 1994 Apr 25;171(1-2):77-80. doi: 10.1016/0304-3940(94)90609-2. Neurosci Lett. 1994. PMID: 7916141

7

Neuroprotective activities of carvedilol and a hydroxylated derivative: role of membrane biophysical interactions.

Lysko PG, Lysko KA, Webb CL, Feuerstein G, Mason PE, Walter MF, Mason RP. Lysko PG, et al. Among authors: lysko ka. Biochem Pharmacol. 1998 Dec 15;56(12):1645-56. doi: 10.1016/s0006-2952(98)00275-5. Biochem Pharmacol. 1998. PMID: 9973186

8

Induced expression of adipophilin mRNA in human macrophages stimulated with oxidized low-density lipoprotein and in atherosclerotic lesions.

Wang X, Reape TJ, Li X, Rayner K, Webb CL, Burnand KG, Lysko PG. Wang X, et al. Among authors: lysko pg. FEBS Lett. 1999 Nov 26;462(1-2):145-50. doi: 10.1016/s0014-5793(99)01521-5. FEBS Lett. 1999. PMID: 10580108 Free article.

9

A comparison of carvedilol and metoprolol antioxidant activities in vitro.

Lysko PG, Webb CL, Gu JL, Ohlstein EH, Ruffolo RR Jr, Yue TL. Lysko PG, et al. J Cardiovasc Pharmacol. 2000 Aug;36(2):277-81. doi: 10.1097/00005344-200008000-00020. J Cardiovasc Pharmacol. 2000. PMID: 10942172

10

Neuroprotective effects of tetrodotoxin as a Na+ channel modulator and glutamate release inhibitor in cultured rat cerebellar neurons and in gerbil global brain ischemia.

Lysko PG, Webb CL, Yue TL, Gu JL, Feuerstein G. Lysko PG, et al. Stroke. 1994 Dec;25(12):2476-82. doi: 10.1161/01.str.25.12.2476. Stroke. 1994. PMID: 7974592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters